COVID-2019 Alert

The latest information about the 2019 Novel Coronavirus, including vaccine clinics for 12-17 year-olds.

La información más reciente sobre el nuevo Coronavirus de 2019, incluidas las clínicas de vacunación para jóvenes de 12 a 17 años.


Caroline Okorie, MD

  • Caroline Uchechi Adanma Okorie

I am both a pediatric pulmonologist and sleep specialist, so I have the opportunity to care for a diverse group of patients with a variety of health issues. I provide care for patients starting from when they're neonates up until they're adults. I enjoy educating patients, families and communities about how to best partner with their medical team to optimize our patients' health and quality of life. I strive to empower patients and families to feel that we are all part of a team working to achieve the best outcome. Everyone should feel like they're part of the solution.



Sleep Disorders


Work and Education

Professional Education

University of Arizona College of Medicine, Tucson, AZ, 05/15/2010


Oregon Health & Science University, Portland, OR, 06/30/2014


Stanford University School of Medicine - Office of Graduate Affairs - Postdoctoral Affairs, Stanford, CA, 06/30/2017

Stanford University School of Medicine - Office of Graduate Affairs - Postdoctoral Affairs, Stanford, CA, 06/30/2018

Board Certifications

Pediatric Pulmonary, American Board of Pediatrics

Pediatrics, American Board of Pediatrics

Sleep Medicine, American Board of Pediatrics

Conditions Treated



Bronchopulmonary Dysplasia

Chronic Cough

Chronic Lung Disease in Infancy

Chronic Ventilator Management

Ciliary Dyskinesias

Congenital Lung Disease

Cystic Fibrosis

Interstitial Lung Disease



Neuromuscular Disease


Pulmonary Hypertension

Pulmonary Vascular Disease

Sleep Disorders

Sleep Medicine

All Publications

ATS Core Curriculum 2020. Pediatric Pulmonary Medicine. ATS scholar Gross, J. E., McCown, M. Y., Okorie, C., Bishay, L. C., Dy, F. J., Rettig, J. S., Baker, C. D., Balmes, J. R., Barber, A. T., Bose, S. K., Casey, A., Hawkins, S. M., Kass, A., Keim, G., Mokhallati, N., Montgomery, G., Peranteau, W. H., Serrano, R., Vece, T. J., Yehya, N., Boyer, D., Hayes, M. M. 2020; 1 (4): 45675


The American Thoracic Society Core Curriculum updates clinicians annually in adult and pediatric pulmonary disease, medical critical care, and sleep medicine, in a 3- to 4-year recurring cycle of topics. These topics will be presented at the 2020 International Conference. Below is the pediatric pulmonary medicine core, including pediatric hypoxemic respiratory failure; modalities in noninvasive management of chronic respiratory failure in childhood; surgical and nonsurgical management of congenital lung malformations; an update on smoke inhalation lung injury; an update on vaporizers, e-cigarettes, and other electronic delivery systems; pulmonary complications of sarcoidosis; pulmonary complications of congenital heart disease; and updates on the management of congenital diaphragmatic hernia.

View details for DOI 10.34197/ats-scholar.2020-0022RE

View details for PubMedID 33870313

The nocturnal-polysomnogram and "non-hypoxic sleep-disordered-breathing" in children SLEEP MEDICINE Guilleminault, C., Huang, Y., Chin, W., Okorie, C. 2019; 60: 3144
Sleep The Handbook of Personal Health and Wellbeing for Physicians and Trainees Okorie, C. U. edited by Weiss Roberts, L., Trockel, M. Springer International Publishing. 2019


OBJECTIVE: To characterize sleep-disordered breathing patterns not related to hypoxia resulting in fragmented sleep in children.METHODS: We reviewed the polysomnogram (PSG) data of children with sleep complaints who were being evaluated for sleep-disordered breathing and had an apnea-hypopnea-index3. These data were compared to the recordings of the same children with nasal CPAP administered for one night and to 60 control subjects (children without any sleep complaints). A subgroup of children was monitored with esophageal manometry, but nasal cannula flow data was recorded in all cases.RESULTS: Abnormal breathing patterns, particularly flow limitation, could be seen with more severity and frequency compared to apnea or hypopnea. The observed abnormal breathing patterns were associated with EEG disturbances.CONCLUSIONS: Patterns such as flow-limitation, mouth-breathing, changes in inspiratory and expiratory time, rib-cage and expiratory muscle activity, transcutaneous CO2 electrode changes and snoring noises are all variables that should be systematically reviewed when analyzing nocturnal PSG. Current scoring guidelines emphasizes apnea-hypopnea and hypoxic-sleep disordered breathing and therefore treatment is often much delayed in this population of children with evidence of abnormal breathing patterns. Analysis of the various patterns of abnormal breathing noted above allows recognition of "non-hypoxic" sleep-disordered-breathing (SDB).

View details for PubMedID 30578113

The nocturnal-polysomnogram and "non-hypoxic sleep-disordered-breathing" in children. Sleep medicine Guilleminault, C., Huang, Y., Chin, W., Okorie, C. 2018
Diagnosis And Management Of Sporadic Pulmonary Arteriovenous Malformation Not Associated With Hereditary Hemorrhagic Telangiectasia Okorie, C., Bhargava, S. AMER THORACIC SOC. 2016

View details for DOI 10.3390/jof2020017

Allergic Bronchopulmonary Aspergillosis Journal of Fungi Tracy, M. C., Okorie, C. A., Foley, E. A., Moss, R. B. 2016; 2 (2): 17


Allergic bronchopulmonary aspergillosis (ABPA), a progressive fungal allergic lung disease, is a common complication of asthma or cystic fibrosis. Although ABPA has been recognized since the 1950s, recent research has underscored the importance of Th2 immune deviation and granulocyte activation in its pathogenesis. There is also strong evidence of widespread under-diagnosis due to the complexity and lack of standardization of diagnostic criteria. Treatment has long focused on downregulation of the inflammatory response with prolonged courses of oral glucocorticosteroids, but more recently concerns with steroid toxicity and availability of new treatment modalities has led to trials of oral azoles, inhaled amphotericin, pulse intravenous steroids, and subcutaneously-injected anti-IgE monoclonal antibody omalizumab, all of which show evidence of efficacy and reduced toxicity.

View details for PubMedID 29376934

Allergic Bronchopulmonary Aspergillosis. Journal of fungi (Basel, Switzerland) Tracy, M. C., Okorie, C. U., Foley, E. A., Moss, R. B. 2016; 2 (2)
A Presentation Of Hepatopulmonary Syndrome In A Five Year Old During Evaluation For Miliary Tuberculosis Okorie, C. U., Mark, J. D. AMER THORACIC SOC. 2015
Successful Treatment Of Mineral Oil Associated Lipoid Pneumonia In An Infant Okorie, C., Powers, M. AMER THORACIC SOC. 2013